Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues, net:    
Total Net Revenues $ 6,274,399 $ 6,493,870
Cost of Sales:    
Total Cost of Sales 3,031,660 3,608,557
Gross Profit 3,242,739 2,885,313
Operating Expenses:    
Research and development 1,129,957 1,177,282
Selling, general and administrative 4,289,920 4,754,783
Depreciation and amortization 43,471 58,853
Total Operating Expenses 5,463,348 5,990,918
Operating Loss (2,220,609) (3,105,605)
Other Income (Expenses):    
Gain on debt extinguishment 1,836,780 0
Interest expense, net (21,067) (21,645)
Total Other Income (Expense) 1,815,713 (21,645)
Loss before Provision for Income Taxes (404,896) (3,127,250)
Income Tax Provision 7,889 22,602
Net Loss $ (412,785) $ (3,149,852)
Net Loss per Common Share:    
Basic - net loss attributable to common stockholders $ (0.00) $ (0.02)
Diluted - net loss attributable to common stockholders $ (0.00) $ (0.02)
Weighted Average Common Shares Outstanding - basic 136,311,335 136,231,562
Weighted Average Common Shares Outstanding - diluted 136,311,335 136,231,562
Product [Member]    
Revenues, net:    
Total Net Revenues $ 5,542,404 $ 5,742,251
Cost of Sales:    
Total Cost of Sales 2,978,886 3,527,977
Recurring [Member]    
Revenues, net:    
Total Net Revenues 731,995 751,619
Cost of Sales:    
Total Cost of Sales $ 52,774 $ 80,580